Expansion Opportunities Orpyx is expanding its sensory insole platform and regional footprint, with recent office expansions and a scalable next-generation solution aimed at preventing diabetic foot complications. This presents a sales angle to pursue multi-region hospital systems, integrated care networks, and payer partnerships seeking scalable diabetic foot prevention programs.

Growth Financing A recent $20M growth capital round led by Perceptive Advisors signals investor confidence and potential for accelerated market penetration, channel partnerships, and joint development opportunities with health tech integrators and device manufacturers.

Clinical Remote Care Orpyx’s remote patient monitoring team and data-driven care model offer a compelling value proposition for health systems aiming to reduce diabetic foot ulcers and amputations, creating opportunities for hospital networks, bundled payment programs, and chronic disease management contracts.

Cost-of-Non-Compliance Media coverage highlights the substantial cost burden of diabetic foot complications, providing a talking point to engage payers and health plans about ROI, reduced readmissions, and long-term savings through the Orpyx Sensory Insole program.

Strategic Partnerships With a solid technology stack and regulatory posture (SOC 2, credentialed care team), there is potential to partner with orthopedic, endocrinology, and diabetes management platforms, as well as hospital EHR ecosystems, to embed or co-market Orpyx solutions.